INS and metabolic syndrome: For example, dyslipidemia (i.e., increased triglycerides, reduced high density lipoprotein cholesterol), which is a key predictor in cardiovascular mortality with cigarette smoking [170], is significantly worse in smokers with insulin resistance compared with more insulin-sensitive smokers [171,172].